The client was launching a branded NSAID tablet medicine into a highly genericized market with entrenched brands.
We proposed to solve the client’s challenge for a successful launch by delivering a strong value proposition to the Payers via our Account Managers while deploying the client’s Product Y sales team into MSA territories with both high decile prescribers AND access to reimbursement.
Within six months post-launch, our Account Management team had attended more than 100 calls, including 14 clinical presentations with Payers.
Reflecting our values:
Partnership – we developed the solution hand in hand with the client.
Ingenuity – this approach was the first of its kind in the market – untested but it delivered.
“We gave Steve, Bill and their team our toughest problem. Ashfield Market Access delivered big time – insight, experience, intensity, and most importantly, results. There were no empty ‘conceptual strategic frameworks’ here, just timely, actionable recommendations based upon deep customer understanding. We used these recommendations to inflect the sales curve. Partnership at its best!”